Lilly Ventures
Est. dry powder
—
Not reported
AUM
—
Not reported
Latest fund
$50M
e.Lilly Venture Fund
Est. cheque size
$500K–
From fund sizes
Deals, last 12 months
4
Last seen investing Jun 2026
About Lilly Ventures
Lilly Ventures is the US-based venture capital arm of Eli Lilly. The firm focuses on early-stage investments in biotechnology, biopharmaceuticals, information technology in North America, Europe, Asia, and the US.
- Type
- Private Equity Firm
- Headquarters
- Indianapolis, Indiana, US
- Stages
- SeedSeries ASeries BSeries CSeries DSeries ESeries FVenture Debt+1
- Est. cheque size
- $500K–$5.3M
- Sectors
- Healthcare
- Regions
- North America
- Strategies
- Pre-Seed, Seed, Series A
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- Series A25
- Series B23
- Series C21
- Series D13
- Series E11
Across 101 deals
Portfolio sectors
- Biotechnology32
- Pharmaceuticals15
- Healthcare IT5
- Healthcare1
- Internet1
Across 55 companies
Portfolio countries
- US49
- UK4
- Denmark1
- Israel1
Across 55 companies
Recent investments
Newest 5 of 101
- Unspecified Round—
Abridge AI, Inc.
Jun 2026 · Unspecified Round
- Series C$435M
Newlimit, Inc.
Jun 2026 · Series C
- Series A$32M
Quarry Thera, LLC
Nov 2025 · Series A
- Series B$65M
Gate Bioscience, Inc.
Nov 2025 · Series B
- Series B$45M
Newlimit, Inc.
Oct 2025 · Series B
Offices
2 locations
- Indianapolis, Indiana, USHQ
- Indianapolis, Indiana, US
Questions about Lilly Ventures
How much does Lilly Ventures invest per deal?
Based on the size of its funds, Lilly Ventures writes estimated cheques of $500K–$5.3M. Lead cheques usually sit at the top of that range and follow-on cheques lower.
What stages does Lilly Ventures invest in?
Lilly Ventures has invested at Seed, Series A, Series B, Series C, Series D and Series E. Its most frequent rounds on record are Series A, Series B and Series C.
What has Lilly Ventures invested in recently?
Recent investments include Abridge AI, Inc., Newlimit, Inc. and Quarry Thera, LLC. It made 4 investments in the last 12 months.